Written by admin on March 3rd, 2008
NEWS: March 3, 2008
The City of Las Vegas went into action and has now closed the Endoscopy Center of Nevada.
City officials have revoked the business license on Friday afternoon. This was in response to the story dated last week of over 40,000 people who may have been infected with HIV, Hepatitis C and other blood borne diseases. The outbreak was from the clinic sharing vials of medication.
Mayor Oscar Goodman said the clinic’s business license would be suspended until further notice.
The clinic issued a statement Wednesday saying it had cleaned up its practices and was cooperating with the health district’s investigation. For more information on this please visit: http://resource4thepeople.com/medicalmalpractice/anesthesiaerrors.html
Written by admin on February 28th, 2008
News: February 28, 2008
The Southern Nevada Health District is advising patients who received injected anesthesia medication at the Endoscopy Center of Nevada, located at 700 Shadow Lane, of a risk for possible exposure to hepatitis C and other bloodborne pathogens.
The health district is recommending patients who had procedures requiring injected anesthesia at the clinic between March 2004 and January 11, 2008, contact their primary care physicians or health care providers to get tested for hepatitis C as well as hepatitis B and HIV.
The Southern Nevada Health District alerted patients that had received injected anesthesia medicine during medical procedures at the Endoscopy Center of Nevada, located at 700 Shadow Lane, of high risk exposure and possible contraction of Hepatitis C, Hepatitis B, HIV and other possible blood borne diseases. All people that had procedures between March 2004 and January 11, 2008 and instructed to seek medical attention from their doctors or health care providers immediately to be tested for infection.
For detailed information about this Hepatitis C Outbreak in Nevada please visit this website: http://resource4thepeople.com/medicalmalpractice/anesthesiaerrors.html
Written by admin on February 19th, 2008
NEWS: February 19, 2008 Bayer Drug Trasylol.
60 Minutes does show on Bayer Drug Trasylol.
A renowned medical researcher estimates that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago. In a scathing documentary the television show 60 Minutes tells of one researcher’s findings on the Bayer drug Trasylol.
Featured in the TV show is San Francisco medical researcher, Dr. Dennis Mangano who studied the drug use in 5,065 patients in 17 countries. His studies indicated that patients that were given Trasylol had a greater risk for renal (kidney) failure and other complications.
“It showed an important association between Trasylol use and kidney failure requiring dialysis, Mangano tells Pelley, “And it showed a trend toward increased death in hospital in these patients.”
The story goes on to illustrate that Bayer had known the drug was unsafe and did not halt sales. The story also talks about the current role the FDA has in testing these drugs. For more information on Trasylol visit this site: http://www.resource4trasylolinfo.com/
Written by admin on February 13th, 2008
NEWS: February 13, 2008
Johnson & Johnson Duragesic Pain Patch Flaw Recall
A recall has been issued by Johnson & Johnson and Novartis AG’s Sandoz on 25-microgram-per-hour patches with expiration dates on or before December 2009.
It was found that a manufacturing problem led to some of the patches having a cut in the internal reservoir lining. This cut may cause a leaking problem of the patch.
The danger is if anyone touches a defective pain patch they may be delivered a dose of the prescription painkiller fentanyl which may lead to breathing problems or even an accidental overdose.
Back in December the FDA issued a safety warning on the Duragesic patch, citing improper use may cause breathing difficulties and death.
The FDA continues to work with J& J on this voluntary recall and is investigating this latest issue.
For more information on the Duragesic Pain Patch Recall please visit: http://www.resource4duragesicrecall.com/
Written by admin on February 11th, 2008
Monday, February 11, 2008
The FDA announced a voluntary recall of Chattem, Inc. “Icy Hot Heat Therapy products” due to consumer reports side effects and injuries involving first, second and third degree burns and skin irritation. The following lots and sizes were recalled:
Icy Hot Heat Therapy Air Activated Heat - Back
Icy Hot Heat Therapy Air Activated Heat - Arm, Neck, and Leg
Icy Hot Heat Therapy Air Activated Heal - Arm, Neck, and Leg single consumer use “samples” on a limited promotional basis in cartons of 3 oz. Aspercreme Pain Relieving Cream
The FDA states “Consumers who have the Icy Hot Heat Therapy products under this recall should immediately stop using the products, discard them, and /or return them to the manufacturer.”
For information or if you’ve had any injury from the Icy Hot Therapy Products visit this website and view the “Breaking News Tab” http://www.resource4thepeople.com
Written by admin on February 8th, 2008
February 8, 2008
The FDA issued an early communication about an ongoing safety review regarding Botox and Botox Cosmetic.
FDA has received reports of systemic adverse reactions including respiratory compromise and death following the use of botulinum toxins types A and B for both FDA-approved and unapproved uses. The reactions reported are suggestive of botulism, which occurs when botulinum toxin spreads in the body beyond the site where it was injected. The most serious cases had outcomes that included hospitalization and death, and occurred mostly in children treated for cerebral palsy-associated limb spasticity. Use of botulinum toxins for treatment of limb spasticity (severe arm and leg muscle spasms) in children or adults is not an approved use in the U.S. See the FDA’s “Early Communication about an Ongoing Safety Review” for Agency recommendations and additional information for healthcare professionals.
For more information about the dangers of Botox visit: http://www.resource4thepeople.com/defectivedrugs/botox.html
Written by admin on February 6th, 2008
February 6, 2008
The FDA has stated it decision to take enforcement action against any company marketing injectable Colchicine that is unapproved. Anextremely toxic drug, Colchicine is used to treat gout and can very easily be given in excessive doses, resulting in serious side effects, low blood counts, organ failure, cardiac events and even death.
The FDA has received 50 reports of events involving injectable Colchicine, 23 of which resulted in death.
The FDA states, “Individuals and companies must stop making these products within 30 days and stop shipping the product within 180 days or face regulatory action. After these dates, all injectable colchicine drug products must have FDA approval to be manufactured or shipped interstate.” For information please visit this web site: http://resource4thepeople.com/recalleddrugs/colchicine.html
Written by admin on February 6th, 2008
February 6, 2008
The government announced Wednesday that the 10,000 patient ACCORD clinical trial involving diabetes treatment has been halted 18 months early due to increased risk of patients death. The trial was stopped after the Data Safety and Monitoring Board found that the rigorous treatment increased the patients’ risk of death by 25%.
The results bring into question the methods used of lowering blood sugar actually protects the heart and is very likely to call the safety of the diabetes drug Avandia into question, yet again.
Although the research does not indicate a link between Avandia use and increased deaths, Steve Nissen, who linked Avandia use to increased risk of heart attacks, states, ““It’s very hard to sort out,” and “We’ve got to be careful not to jump to conclusions.”. Nissen went on to say “Clinicians have been taught that getting to lower blood sugar is better” and “its really going to shake things up”.
Avandia was recently back in the news, when it was found that Dr Steven Haffner, admitted leaking information about a study linking the drug to a 43% greater risk of heart attacks to GlaxoSmithKline PLC 17 days before the article was published in the New England Journal of Medicine, last May.
For more information about Avandia please visit this website: http://resource4thepeople.com/defectivedrugs/avandia.html
Written by admin on January 31st, 2008
January 31, 2008 FDA study shows some antiepileptic drugs may increase the risk of suicidal behavior:
The drugs listed below used to treat epilepsy and other disorders identified to increase the risk for suicidal behavior.
The FDA looked at 11 drugs:
Carbamazepine (Carbatrol, Equetro, Tegretol, Tegretol XR)
Felbamate (Felbatol)
Gabapentin (Neurontin)
Lamotrigine (Lamictal)
Levetiracetam (Keppra)
Oxcarbazepine (Trileptal)
Pregabalin (Lyrica)
Tiagabine (Gabitril)
Topiramate (Topamax)
Valproate (Depakote, Depakote ER, Depakene, Depacon)
Zonisamide (Zonegran)
If you have lost a loved one to suicide due to use any of the antiepileptic drugs listed and would like to learn your legal rights, please contact us by calling toll free at 1-866-242-0905. Or visit the “In the news” tab on this website: http://www.resource4thepeople.com/defectivedrugs/
Written by admin on January 31st, 2008
January 31, 2008 The FDA announced a recall to consumers and healthcare professionals that NuCel Labs has voluntarily recalled all Eye Drops and Eye/Wash Products. This is a nationwide recall due to testing which indicated potential bacteria and particulate matter making the products non-sterile. Use of the products poses an unacceptable risk of eye infections and in rare cases blindness or loss of vision.
There are presently no reported injuries and consumers are asked to discontinue use and immediately return the product to NuCel Lab. If you or a loved has been injured from using these products please seek immediate medical attention.
For more information visit: http://www.resource4thepeople.com/recalleddrugs/
